Updates are available Correction dated 2019-01-24
Click to view Correction: https://doi.org/10.1186/s13046-019-1022-5
-
Authors
Lin, Cheng
Zong, Jingfeng
Lin, Wansong
Wang, Minghui
Xu, Yuanji
Zhou, Rui
Lin, Shaojun
Guo, Qiaojuan
Chen, Honglin
Ye, Yunbin
Zhang, Bin
Pan, Jianji
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (U1405221)
- License Information
-
More Information
Article History
Received: 26 September 2018
Accepted: 7 November 2018
First Online: 26 November 2018
Change Date: 24 January 2019
Change Type: Correction
Change Details: Following publication of the original article [1], the authors reported two errors in the article. In the caption of Figure 1c the sentence “The 20 most highly upregulated EBV BART miRNAs identified between NPC specimens and normal nasopharyngeal mucosal specimens" should be corrected as “The highly upregulated EBV BART miRNAs identified between NPC specimens and normal nasopharyngeal mucosal specimens”.
Ethics approval and consent to participate
: This study was approved by the Ethical Review Committee of Fujian Cancer Hospital (approval no. FJZLYY2016–00143). Written informed consent was obtained from all participants following a detailed description of the purpose of the study. All experiments described in this study were conducted in accordance with international and national laws, regulations and guidelines.
: All authors consent for publication.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
